Table 4. The predictive development of metabolic syndrome and its components (%) in individuals starting with no component according to the Markov chain models.
| Young men | Young women | ||||||||
| Year 1 | Year 5 | Year 10 | Year 15 | Year 1 | Year 5 | Year 10 | Year 15 | ||
| No component | 100 | 92.89 | 71.88 | 56.15 | 46.71 | 92.82 | 72.30 | 57.89 | 49.81 |
| Isolated abdominal obesity | 0 | 0.91 | 3.30 | 4.68 | 5.28 | 1.67 | 5.77 | 7.78 | 8.41 |
| Isolated high TGa | 0 | 1.08 | 3.71 | 4.94 | 5.26 | 0.32 | 1.00 | 1.23 | 1.26 |
| Isolated low HDL | 0 | 0.74 | 2.40 | 3.02 | 3.09 | 2.73 | 9.13 | 11.85 | 12.41 |
| Isolated high BP | 0 | 1.99 | 6.80 | 8.91 | 9.32 | 0.41 | 1.50 | 2.19 | 2.52 |
| Isolated high FPG | 0 | 0.20 | 0.76 | 1.13 | 1.31 | 0.16 | 0.49 | 0.60 | 0.64 |
| 2 components | 0 | 1.73 | 7.64 | 12.88 | 16.34 | 1.49 | 6.77 | 11.43 | 14.32 |
| MetS | 0 | 0.45 | 3.52 | 8.30 | 12.69 | 0.41 | 3.04 | 7.04 | 10.63 |
a
TG, triglyceride; HDL, high-density lipoprotein cholesterol; BP, blood pressure; FPG, fasting plasma glucose; MetS, metabolic syndrome.